Articles On Polynovo (ASX:PNV)

There’s been a breakthrough in acne treatment Scientists have found a way to use skin bacteria to control sebum production We look at the best and worst performing ASX health stocks in the past month   Scientists have made a significant b...

It was a mildly disappointing Wednesday for ASX investors today, with the S&P/ASX 200 Index (ASX: XJO) recording a slight loss. After spending most of the day in green territ...

The S&P/ASX 200 Index (ASX: XJO) enjoyed another positive session today, as the recovery from last week's slump continues. A confident session saw the ASX 200 add a decent 0.4...

New ImpediMed leadership team and board committed to company’s success  Private payor and Medicare coverage for SOZO device reaches critical mass in 16 US states ImpediMed prioritises 11 US states for growth as looks to boost sales and ach...

The S&P/ASX 200 Index (ASX: XJO) has concluded the week's trading on a decidedly high note. Literally. For today, the ASX 200 minted a fresh new all-time h...

ASX Health Index down -1.5% for February 76 biotechs rose, and 78 fell during the month But essentially, biotech is a long term game for investors   The S&P/ASX 200 Health Care [XHJ] struggled in February, finishing -1.5% lower and tr...

Polynovo to get first orders of NovoSorb BTM in India Clinuvel Pharma reports positive results from Phase 2 study   Polynovo approved for Indian government e-portal site Polynovo (ASX:PNV) announced that the Indian government has approved...

ASX health sector lifts in line with broader markets as reporting season comes to end Morgans upgrades Polynovo as total revenue rises 65.6% on pcp to $48.8 million  Nanosonics cites hospital budgetary pressures as deferring purchasing dec...

The S&P/ASX 200 Index (ASX: XJO) overcame a slow and shaky start this morning to post a convincing gain by the close of trading this Thursday. After falling at m...

ASX closed higher after rallies in Harvey Norman, Star Casino stocks Bitcoin jumped to US$62k US inflation data due later tonight, will signal if bull market is over   The ASX 200 swung to a higher close on Thursday, up +0.5%, after openi...

Viking Therapeutics doubled after results of weight loss drug trial Janux Therapeutics tripled on pancreatic cancer results We look at the recent best performing ASX health stocks   There were a couple of big news from the world of biotec...

It ended up being another volatile day for the S&P/ASX 200 Index (ASX: XJO) this Wednesday. But, unlike yesterday, ASX shares failed to snatch a last-minute win....

Lithium miners surge NextDC also jumps on strong H1, but Flight Centre tumbles Aussie inflation lowest in two years   The ASX 200 closed modestly lower on Wednesday with, with gains in Tech offset by losses in Comm Services and Staples se...

Three S&P/ASX 200 Index (ASX: XJO) shares just scored significant broker upgrades. The analysts' bullish assessments for these companies, including share price gains of up to 13%, follow on the release of yesterday's earnings results....

ASX 200 healthcare shares are among the worst-performing market sectors on Tuesday, with the S&P/ASX 200 Health Care Index (ASX: XHJ) down 0.86% at the time of writing. Meantime, the S&P/ASX 200 Index (ASX: XJO) is also lower, dow...

Biotech doesn’t need another pandemic for a resurgence – it’s made a strong comeback regardless. Stockhead spoke with Andrew Chapman, head of Perth-based fundie Merchant Group – to learn why this is the case, and which are his top picks for...

June of 2015 was a special time. The vastly underrated Jurassic World was about to become the first film to make US$500m worldwide on its opening weekend and in Harare, President Robert Mugabe had just discarded the national currency in fav...

Morgans releases its ASX wound care report seeing value in Aroa Biosurgery, Avita Medical and PolyNovo Global wound care market is estimated to grow at a CAGR of 5.9% to reach US$28.6 billion by 2028 ASX wound care companies head towards p...

Xi and Biden set to agree on restricting fentanyl  Fentanyl is a synthetic opioid responsible for the opioids epidemic in the US We look at the best performing health stocks over the past couple of weeks   China’s President Xi is expected...

After yesterday's hiccup, the strong run the S&P/ASX 200 Index (ASX: XJO) has been on this November continued today. By the close of trading, the ASX 200 add...

Aroa Biosurgery forecasts business growth of up to 30% annually with product revenue guidance of NZ$73-$76 million in FY24 New study highlights positive outcomes using Myriad Matrix and Myriad Morcells in complex traumatic wounds Aroa focu...

Highlights The products of PolyNovo comprise NovoSorb Biodegradable Temporizing Matrix (BTM) and NovoSorb technology In FY23, PNV’s annual revenue zoomed by nearly 56.80%, backed by significant sales growth in the US market In FY24, r...

ASX tumbles after Nasdaq rout overnight Azure Minerals accepts takeover from Chliean giant SQM Megaport sinks 20pc after Q1 results   The ASX 200 dropped -0.8% on Thursday following a selloff on the Nasdaq and S&P 500 index overnight....

It's been a pretty depressing day for most ASX shares and the S&P/ASX 300 Index (ASX: XKO) this Thursday so far. At present, the ASX 300 has shed a horrid 0.86%, leaving the index at just 6,748.3 points. But let's talk about one ASX 30...

It's been a horrible start to the trading week for the S&P/ASX 200 Index (ASX: XJO) this Monday. After heavy falls last Thursday and Friday, investors hoping for a repri...

News relating to Novo Nordisk’s Ozempic has led to a selloff in some ASX stocks CSL, FPH, and RMD fell heavily last week But Goldman analysts say they won’t change ratings on these 3 stocks   Goldman Sachs analysts said they will make no...

The S&P/ASX 300 Index (ASX: XKO) has had a positive start to this Tuesday's trading session, shaking off the negative we saw yesterday. At the time of writing, the ASX 300 has gained a rosy 0.62%, putting the index back above 7,000 poi...

The Syrah Resources Ltd (ASX: SYR) share price is having a strong start to the day. In morning trade, the graphite producer's shares are up 5% to 49.5 cents. Why is the Syrah share price jumping? Investors have been buying Syrah's shares t...

Weekly update on stockbroker recommendation, target price, and earnings forecast changes. By Mark Woodruff Guide: The FNArena database tabulates the views of eight major Australian and international stockbrokers: Citi, Bell Potter, Macquari...

INOVIQ Limited (ASX: IIQ) has announced the appointment of David Williams as a Non-Executive Director and Chairman Elect, effective from the Annual General Meeting (AGM) scheduled for 29 November 2023. Mr Williams will succeed Dr Geoffrey C...

There's nothing like backing a winner, right? If you see ASX shares that are on an upward curve, and you feel like the business can continue the momentum, why wouldn't you jump on? Here are two such stocks that the team at Celeste Funds Ma...

ASX health sector falls in line with broader markets as macroeconomic factors continue to create volatility Dimerix soars on $230m licensing deal with ADVANZ PHARMA for DMX-200 into rare kidney disease US FDA approves Cyclofarm’s lung imag...

When a stock almost doubles in just one year, the natural thought for punters who don't own it is to think "It's too late to get in on that action". But ASX shares don't have memory. It doesn't care what's happened the past 12 months, one...

The S&P/ASX 200 Index (ASX: XJO) has returned to form and is pushing higher at last on Thursday. In afternoon trade, the benchmark index is up 0.5% to 6,924.9 points. Four ASX shares that are climbing more than most today are listed b...

The S&P/ASX 200 Index (ASX: XJO) has fought back from a tough start and is now trading just a fraction lower. At the time of writing, the benchmark index is down 2.2 points to 7,046.4 points. Four ASX shares that are trying their bes...

The S&P/ASX 200 Index (ASX: XJO) stock Scentre Group (ASX: SCG) has been hurting a lot. Since the start of 2023, the Scentre share price has fallen 14%. It's down 20% from 24 January 2023 and it's down around 40% from mid-January 2020....

Investing, like most other activities in life, requires practice and experience for any human to become competent at it. In fact, some people may never even reach competency even after years of training. So when those who have done it succ...

With apologies to Charles Dickens, it’s the best of times and the worst of times for wound care house Next Science (ASX:NXS) as it shapes itself up for a renewed market assault under a new CEO. On the positive side of the ledger, the compan...

L’Oréal to take minority stake in Chinese startup Shinehigh Innovation Shinehigh is developing supramolecular technology which could be used in the fashion industry Best and worst performing ASX biotechs over the past couple of weeks   Be...

The S&P/ASX 200 Index (ASX: XJO) is down 0.28% to 7,018.5 points in afternoon trade following a slump on Wall Street last night. Part of the burdensome weight on the share market's shoulders is the rising yield on bonds. Overnight, th...

Pro Medicus Limited (ASX: PME) shares were on fire on Tuesday despite the market weakness. The health imaging technology company's shares stormed 12% higher to a record high. Investors were scrambling to get hold of its shares after it an...

It was back to old, bad habits for the S&P/ASX 200 Index (ASX: XJO) during Tuesday's trading session. After the ASX 200 snapped its five-day losing streak yesterday with a tentative gain...

The S&P/ASX 200 Index (ASX: XJO) is out of form on Tuesday. In afternoon trade, the benchmark index is down 0.5% to 7,043.1 points. Four ASX shares that are not letting that hold them back are listed below. Here's why they are pushing...

It hasn't been a great day for the S&P/ASX 200 Index (ASX: XJO) and most ASX shares so far this Tuesday. At the time of writing, the ASX 200 has slipped by 0.71%. But that hasn't stopped one ASX exchange-traded fund (ETF) from hitting...

Another day, another set of 52-week highs for ASX uranium shares! Most uranium miners are rising on Tuesday, in contrast to the rest of the market. The S&P/ASX 200 Energy Index (ASX: XEJ) started the day higher but is now down 0.19%...

It's been a pretty awful start to this Tuesday's trading for the S&P/ASX 300 Index (ASX: XKO) and ASX 300 shares so far today. At present, the ASX 300 has slipped by 0.32% and is back to around 7,000 points. So given this slip for the...

Australian medical device company PolyNovo (ASX:PNV) has announced that it more than doubled its revenue in August compared to the same month last year.

Another 4% fall in the price of iron ore was almost enough to drive the S&P/ASX200 (INDEXASX: XJO) lower, with the materials sector falling 0.7% to open the week. Both BHP Group Ltd (ASX: BHP) and Rio Tinto Ltd (ASX: RIO) fell by more t...

The S&P/ASX 200 Index (ASX: XJO) has delighted investors hoping for a reprieve from the share market today with a green session. After falling every single trading day last week, the ASX...

The S&P/ASX 200 Index (ASX: XJO) is out of form on Monday. In afternoon trade, the benchmark index is down 0.2% to 7,057 points. Four ASX shares that are not letting that hold them back are listed below. Here's why they are rising:...